Jennison Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,212	Closed	-$637K	–	616
2024 Q1	$637K	Buy	+9,212	New	+$633K	﹤0.01%	542
2023 Q4	–	Sell	-186,867	Closed	-$9.73M	–	629
2023 Q3	$9.73M	Buy	186,867 +24,094	+15%	+$1.4M	0.01%	367
2023 Q2	$10.3M	Buy	162,773 +150,480	+1,224%	+$9.38M	0.01%	375
2023 Q1	$666K	Sell	12,293 -3,761	-23%	-$182K	﹤0.01%	546
2022 Q4	$850K	Sell	16,054 -1,251	-7%	-$62.7K	﹤0.01%	512
2022 Q3	$805K	Buy	17,305 +4,154	+32%	+$217K	﹤0.01%	527
2022 Q2	$751K	Buy	+13,151	New	+$746K	﹤0.01%	551
2017 Q1	–	Sell	-1,024,366	Closed	-$15.5M	–	817
2016 Q4	$15.5M	Sell	1,024,366 -289,150	-22%	-$4.08M	0.02%	442
2016 Q3	$20M	Buy	1,313,516 +33,919	+3%	+$1.37M	0.02%	410
2016 Q2	$49.7M	Buy	1,279,597 +1,987	+0.2%	+$71.4K	0.05%	289
2016 Q1	$35.5M	Buy	1,277,610 +19,764	+2%	+$659K	0.04%	338
2015 Q4	$67.7M	Buy	1,257,846 +855,846	+213%	+$43.2M	0.07%	237
2015 Q3	$16.1M	Buy	+402,000	New	+$13.1M	0.02%	461